Reckitt Benckiser Group plc (OTCMKTS:RBGLY) Short Interest Update

Reckitt Benckiser Group plc (OTCMKTS:RBGLY) saw a large decline in short interest during the month of March. As of March 15th, there was short interest totalling 50,500 shares, a decline of 51.1% from the February 28th total of 103,300 shares. Based on an average daily trading volume, of 609,700 shares, the days-to-cover ratio is presently 0.1 days. Currently, 0.0% of the shares of the stock are short sold.

Reckitt Benckiser Group Stock Up 1.5 %

OTCMKTS:RBGLY traded up $0.20 during midday trading on Friday, reaching $13.56. 183,173 shares of the stock traded hands, compared to its average volume of 336,059. Reckitt Benckiser Group has a 12 month low of $10.24 and a 12 month high of $14.10. The company has a current ratio of 0.69, a quick ratio of 0.47 and a debt-to-equity ratio of 0.97. The company has a fifty day moving average of $13.26 and a 200 day moving average of $12.60.

Reckitt Benckiser Group Increases Dividend

The company also recently announced a dividend, which will be paid on Thursday, June 5th. Stockholders of record on Friday, April 11th will be issued a dividend of $0.2909 per share. This is a positive change from Reckitt Benckiser Group’s previous dividend of $0.19. The ex-dividend date of this dividend is Friday, April 11th.

Analyst Upgrades and Downgrades

A number of research analysts have commented on the stock. Hsbc Global Res upgraded shares of Reckitt Benckiser Group from a “hold” rating to a “strong-buy” rating in a research report on Wednesday, December 11th. Barclays cut shares of Reckitt Benckiser Group from an “overweight” rating to an “equal weight” rating in a research report on Tuesday, February 4th. Royal Bank of Canada restated an “outperform” rating on shares of Reckitt Benckiser Group in a research report on Friday, March 7th. Finally, HSBC upgraded Reckitt Benckiser Group from a “hold” rating to a “buy” rating in a report on Wednesday, December 11th. Three analysts have rated the stock with a hold rating, two have assigned a buy rating and three have issued a strong buy rating to the stock. According to MarketBeat, Reckitt Benckiser Group has an average rating of “Buy”.

About Reckitt Benckiser Group

Reckitt Benckiser Group plc manufactures and sells health, hygiene, and nutrition products worldwide. It offers acne treatment creams, facial washes, and cleansing pads; germ protection products; condoms; heartburn and indigestion solutions; joints health products; chest congestion, cough, and sinus remedies; brain health products; migraine-headaches and rheumatic pain products; sore throat medications; and hair removal products under the Airborne, Clearasil, Dettol, Durex, Gaviscon, Move Free, Neuriva, Nurofen, Mucinex, Strepsils, and Veet brands.